• Mashup Score: 1
    Arterial Grafts in Coronary Artery Bypass Surgery: Who, When, and Why - 10 month(s) ago

    When selecting conduits for coronary artery bypass, long-term patency, survival benefit, and patient factors such as coronary atherosclerotic burden and comorbid conditions are the primary influences on surgical decision-making (Fig. 1). Previous studies have shown that multiple arterial conduits offer a survival benefit,1 but the observational design of this work makes the findings subject to…

    Source: Allen Press
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Texas_Heart
      Texas_Heart

      Global CV Forum / Arterial Grafts in Coronary Artery Bypass Surgery: Who, When, and Why | N Roa-Vidal @LaurenBarronMD @medupr @Texas_Heart @bcmhouston | #THIJournal https://t.co/OVnANas3Md https://t.co/2C5tzk6rWz

  • Mashup Score: 1
    The Past, Present, and Future of Complex Aortic Intervention - 10 month(s) ago

    Albert Einstein once said, “The distinction between the past, present and future is only a stubbornly persistent illusion.”So much of what is done with complex aortic surgical interventions is a direct outgrowth of what has been done, what is being done, and what is intended to be accomplished.The first successful aortic aneurysm repair was performed by Dr Charles Dubost in 1951; he replaced an…

    Source: Allen Press
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Texas_Heart
      Texas_Heart

      Global CV Forum / The Past, Present, and Future of Complex Aortic Intervention | @JCoselli_MD @Texas_Heart @bcmhouston | #THIJournal https://t.co/LexPMny2RH https://t.co/ZnajndiqiA

  • Mashup Score: 0
    Leveraging Innovation to Mitigate Risk During Heart Surgery - 10 month(s) ago

    Innovation is not necessarily about the “next big thing” according to Mehta.1 Instead, innovation can occur by combining existing technologies, developing small ideas that compound, or evolving to address problems that have arisen from previous innovations that yielded unpredictable consequences. Innovation in the field of cardiovascular surgery is no different. As the field becomes progressively…

    Source: Allen Press
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Texas_Heart
      Texas_Heart

      Global CV Forum / Leveraging Innovation to Mitigate Risk During Heart Surgery | @MarcMoonMD @PujaKachroo @Texas_Heart @bcmhouston @WUSTLMed | #THIJournal https://t.co/WbLCfGneaX https://t.co/KUj4RwNRvw

  • Mashup Score: 0
    Cutting-Edge Trials in Structural Heart Disease at The Texas Heart Institute - 10 month(s) ago

    Mitral and tricuspid valvular disease have been managed surgically; however, multiple transcatheter technologies have diversified the therapeutic arsenal and expanded the number of patients eligible for treatment. These new technologies and active trials currently being performed at The Texas Heart Institute will be highlighted.Transcatheter edge-to-edge repair (TEER) with MitraClip (Abbott…

    Source: Allen Press
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Texas_Heart
      Texas_Heart

      Global CV Forum / Cutting-Edge Trials in Structural Heart Disease at The Texas Heart Institute | @YKherallah GV Silva @Texas_Heart @bcmhouston | #THIJournal https://t.co/EHxB1llQzQ https://t.co/jxbY2LPLO9

  • Mashup Score: 2
    P2Y12 Inhibitors for Non–ST-Segment Elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis - 10 month(s) ago

    AbstractBackground. For patients with non–ST-segment elevation acute coronary syndrome (NSTE-ACS), prasugrel was recommended over ticagrelor in a recent randomized controlled trial, although more data are needed on the rationale. Here, the effects of P2Y12 inhibitors on ischemic and bleeding events in patients with NSTE-ACS were investigated.Methods. Clinical trials that enrolled patients with…

    Source: Allen Press
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Texas_Heart
      Texas_Heart

      P2Y12 Inhibitors for Non–ST-Segment Elevation Acute Coronary Syndrome Systematic Review and Network Meta-Analysis @TomohiroFujisa2 @ToshikiKuno Briasoulis Misumida Takagi @azeemlatib @IcahnMountSinai @MontefioreNYC @uihealthcare @UK_HealthCare #THIJournal https://t.co/ZQmvIqTnmu https://t.co/Vs57QXugxS

  • Mashup Score: 0
    Does the Type of Chronic Heart Failure Impact In-Hospital Outcomes for Aortic Valve Replacement Procedures? - 10 month(s) ago

    AbstractBackground. This study assessed in-hospital outcomes of patients with chronic systolic, diastolic, or mixed heart failure (HF) undergoing transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR).Methods. The Nationwide Inpatient Sample database was used to identify patients with aortic stenosis and chronic HF who underwent TAVR or SAVR between 2012 and…

    Source: Allen Press
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Texas_Heart
      Texas_Heart

      Does the Type of Chronic Heart Failure Impact In-Hospital Outcomes for Aortic Valve Replacement Procedures? Mubashir Zaki An SalasDeArmas Liang Markham Feng Akay Nascimbene Akkanti Williams Zasso PatarroyoAponte Gregoric Kar @UTHealthHouston #THIJournal https://t.co/IbIIhB5esw https://t.co/XAnUO3QXOi

  • Mashup Score: 0
    Successful Reuse of a Donor Heart - 10 month(s) ago

    Abstract. At a time when transplantable organs are in a shortage, few cases have noted the reuse of donor hearts in a second recipient in an effort to expand the donor network. Here, we present a case in which an O Rh-positive donor heart was first transplanted into a B Rh-positive recipient and later successfully retransplanted into a second O Rh-positive recipient 10 days after the initial…

    Source: Allen Press
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Texas_Heart
      Texas_Heart

      Successful Reuse of a Donor Heart | Gabriel Esmailian, @KevinQ_Chen @DannyRamzyMD Jon A. Kobashigawa, @JoChikweMD Fardad Esmailian @CedarsSinai @GWSMHS | #THIJournal https://t.co/TBBMDDbQUR https://t.co/PyLWAoAhdB

  • Mashup Score: 0
    The Role of Transcatheter Aortic Valve Implantation in Patients With Bicuspid Valves in 2023 - 10 month(s) ago

    Bicuspid aortic valve (BAV) is the most common congenital heart defect, occurring in 1% to 2% of the general population.1 Compared with individuals having normal tricuspid aortic valves, those with BAVs are more likely to develop calcification on valve leaflets and raphe and dilation of the ascending aorta (aortopathy)—and at a much earlier age. For highly select patients with severe BAV…

    Source: Allen Press
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Texas_Heart
      Texas_Heart

      Global CV Forum / The Role of Transcatheter Aortic Valve Implantation in Patients With Bicuspid Valves in 2023 | @MiladElHajjMD Zvonimir Krajcer @Texas_Heart @BCMHouston | #THIJournal https://t.co/rDlXKTTVtZ https://t.co/gu2Ge8Xxaa

Load More